Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 3.7 Exhibit 3.7 Amendment to Amended and Restated Certificate of Incorporation, As Filed with the Delaware Secretary of State on November 9, 2018
- 10.8 Exhibit 10.8 Settlement Agreement by and Between Tyg Solutions Corp. and Medical Marijuana, Inc.
- 10.9 Exhibit 10.9 Exclusive Patent License Agreement - Exclusive by and Between the National Institutes of Health and Kannalife Sciences, Inc.
- 10.10 Exhibit 10.10 Nonexclusive Patent License Agreement - Nonexclusive by and Between the National Institutes of Health and Kannalife Sciences, Inc.
- 10.11 Exhibit 10.11 Feasibility Study Quotation by and Between Kannalife Sciences, Inc. and Catalent Pharma Solutions, LLC.
- 10.12 Exhibit 10.12 Stock Purchase Agreement by and Between Cross & Co. and the Company
- 21.1 Exhibit 21.1 Schedule of Subsidiaries
- 23.1 Exhibit 23.1 Auditor's Consent
NPTX similar filings
Filing view
External links